Transplantation is the optimal treatment for patients with kidney failure, but rejection still causes premature graft loss in as many as 30 per cent of recipients. This project aims to cut the rejection rate by in half by using genomic technologies to improve the matching of donors and recipients, to monitor the immune response for rejection, and to develop personalized drug treatment regimes for each recipient. It offers the potential for $1 billion in healthcare savings over the next 15 years.
Company Details
- Founded
- -
- Address
- 855 W 12th Ave, Vancouver,british Columbia V5z 1m9,canada
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- http://www.gctransplant.ca/
- Keywords
- IT Consulting.
- HQ
- Vancouver, British Columbia
- Competitors
- UBC Perinatal Anxiety Research Lab (PARLab), T2Mobile, Prestwick Limited, ИТ Контакт, Life Science Recruitment Agency, CANADAS MICHAEL SMITH GENOME SCIENCES CENTRE, ALIVE Research Lab @ UBC, ANESTHESIA AND PAIN CONSULTANTS OF SOUTHWEST FLORIDA, The Future Genome Institute, A V E SYSTEMER AS.
Genome Canada Transplant Consortium Questions
Genome Canada Transplant Consortium's website is http://www.gctransplant.ca/
Genome Canada Transplant Consortium's LinkedIn profile is https://ca.linkedin.com/company/genomecanadatx
Genome Canada Transplant Consortium's industry is
Hospitals and Health Care
Genome Canada Transplant Consortium's top competitors are
Ubc Perinatal Anxiety Research Lab (Parlab),
T2mobile,
Prestwick Limited,
Ит Контакт,
Life Science Recruitment Agency,
Canadas Michael Smith Genome Sciences Centre,
Alive Research Lab @ Ubc,
Anesthesia And Pain Consultants Of Southwest Florida,
The Future Genome Institute,
A V E Systemer As.
Genome Canada Transplant Consortium's categories are Hospitals and Health Care
Genome Canada Transplant Consortium's founding year is 2017
